High activity of an affinity-matured ACE2 decoy against Omicron SARS-CoV-2 and pre-emergent coronaviruses
Joshua J. Sims, Sharon Lian, Rosemary Meggersee, Aradhana Kasimsetty, James M. Wilson
This paper evaluates an ACE2 decoy inhibitor that remains effective against SARS-CoV-2 variants including Omicron BA.1 and BA.2, and shows broad activity against related sarbecoviruses.
PLoS ONE · Aug 25, 2022Peer-reviewedMolecular Biology